EPD initiated at Credit Suisse with an Outperform rating and $38 price target. The company should benefit from build-out of US energy infrastructure, analysts said.
EPE coverage initiated with a Neutral rating and $45 price target, Credit Suisse said. Leverage to EPD provides faster growth, analysts mentioned.
KEY was upgraded to Buy, Goldman Sachs said. Company should benefit from CD re-pricing this year. $10 price target.
NFLX downgraded to Equal Weight from Overweight, Barclays said. Valuation call. Price target jumped to $88 from $72. 2010 and 2011 EPS estimates set at $2.68 and $3.05, respectively.
ODP coverage initiated at Barclays with an Equal Weight rating and $9 price target. 2010 and 2011 EPS estimates set at breakeven and $0.33, respectively.
OMX coverage initiated with an Equal Weight rating and $18 price target. Substantial long-term upside potential, Barclays said. 2010 and 2011 EPS estimates set at $0.53 and $0.87, respectively.
PRXL was downgraded to Market Perform, Wells Fargo said. Valuation call, as the stock is already pricing in strong bookings.
SPLS coverage initiated with an Overweight rating and $28 price target, Barclays said. Positioned to benefit from office supple market. 2011 and 2012 EPS estimates set at $1.35 and $1.65, respectively.
WAB was downgraded to Neutral, Longbow Research said. Estimates also lowered, as transit agencies are taking money out of capital budgets.
AAPL estimates were increased through 2011, UBS said. iPhone sales are tracking ahead of expectations. Buy rating and $280 price target.
AMD estimates were boosted through 2011, UBS said. Company should benefit from positive end-market trends. Buy rating and new $13 price target.
AN estimates were increased through 2012, Goldman Sachs said. Company pre-announced and is seeing a higher gross margin. Sell rating and $17 price target.
AZO price target raised to $195 from $185 as trends remain favorable, Bank of America/Merrill Lynch said. 2010 and 2011 EPS estimates lifted to $13.90 and $15.60, respectively. Maintain Buy.
BAC 2010 EPS estimate increased to $0.85, 2011 held at $1.80. MER spreads widened during the quarter, Barclays said. Maintain Equal Weight rating and $20 price target.
CME estimates were boosted through 2011, UBS said. Company is seeing higher futures volumes. Neutral rating and new $319 price target.
HON price target increased to $57.50 from $48 on improving competitive dynamics in China, Bank of America/Merrill Lynch said. Estimates raised through 2012. Buy rating.
Shares of ICE now seen reaching $125, according to UBS. Estimates also reduced, as pricing has likely dropped. Buy rating.
INTC estimates were raised through 2011, UBS said. Company has a strong new product cycle and should benefit from positive end-market trends. Buy rating and $30 price target.
KMT price target increased to $35 from $32. Best ISM play on our coverage, Bank of America/Merrill Lynch said. Buy rating.
MMM target was raised to $94, Argus Research said. Expect the company to see accelerated growth overseas. Buy rating.
Shares of RL now seen reaching $99, according to UBS. Estimates also increased, as industry checks suggest strong Fall orders. Buy rating.
SHAW price target raised to $39 from $36 as operating environment improves, Barclays said. 2010 and 2011 EPS estimates maintained at $2.20 and $2.60, respectively.
TKR price target jumped to $36 from $32. Chinese & AsiaPac business could provide material upside to earnings in 2011 and beyond, Bank of America/Merrill Lynch said. Reiterate Buy.
TNK price target improved to $12.50 from $10.50 as the company raises cash to grow tanker fleet, Bank of America/Merrill Lynch said. Maintain Neutral rating.
Shares of URBN now seen reaching $44, Jesup & Lamont said. Now see mid-teen comp sales growth in the first quarter. Outperform rating.
XOM 2010 and 2011 EPS estimates lowered to $5.70 and $7.00, respectively. Reiterate Overweight rating and $92, price target.